Skip to main content

Articles

Encouraging Results for Pembrolizumab in Head and Neck Cancer

Elotuzumab, First-in-Class Monoclonal Antibody Immunotherapy, Improves Outcomes in Patients with Multiple Myeloma

Lenvatinib Extends Survival in Metastatic Renal-Cell Carcinoma

Nivolumab Makes Headwinds into Liver Cancer

Study Shows Promise of Precision Medicine for Most Common Type of Lymphoma

Value Propositions in Oncology: The Physician Perspective

Anthem’s Clinical Pathways Demonstrate Value: The Payer Perspective

ASCO’s Value Initiative: A New Framework Seeking to Standardize Patient–Physician Interactions

Communication Gap with Oncologists, Not Cost, Tops Patients’ Value Priorities

ASP plus 6% Will Fall by the Wayside, but What Are the Alternatives?

Page 129 of 244
Results 1281 - 1290 of 2434